These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 30703486)

  • 1. Modulation of nuclear receptor function: Targeting the protein-DNA interface.
    Veras Ribeiro Filho H; Tambones IL; Mariano Gonçalves Dias M; Bernardi Videira N; Bruder M; Amorim Amato A; Migliorini Figueira AC
    Mol Cell Endocrinol; 2019 Mar; 484():1-14. PubMed ID: 30703486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A conserved surface on the ligand binding domain of nuclear receptors for allosteric control.
    Buzón V; Carbó LR; Estruch SB; Fletterick RJ; Estébanez-Perpiñá E
    Mol Cell Endocrinol; 2012 Jan; 348(2):394-402. PubMed ID: 21878368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-function analysis of the Rev-erbA and RVR ligand-binding domains reveals a large hydrophobic surface that mediates corepressor binding and a ligand cavity occupied by side chains.
    Renaud JP; Harris JM; Downes M; Burke LJ; Muscat GE
    Mol Endocrinol; 2000 May; 14(5):700-17. PubMed ID: 10809233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crystal structure of the human LRH-1 DBD-DNA complex reveals Ftz-F1 domain positioning is required for receptor activity.
    Solomon IH; Hager JM; Safi R; McDonnell DP; Redinbo MR; Ortlund EA
    J Mol Biol; 2005 Dec; 354(5):1091-102. PubMed ID: 16289203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evolution of a novel subfamily of nuclear receptors with members that each contain two DNA binding domains.
    Wu W; Niles EG; Hirai H; LoVerde PT
    BMC Evol Biol; 2007 Feb; 7():27. PubMed ID: 17319953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evolution of the repertoire of nuclear receptor binding sites in genomes.
    Cotnoir-White D; Laperrière D; Mader S
    Mol Cell Endocrinol; 2011 Mar; 334(1-2):76-82. PubMed ID: 21056084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diversity of Quaternary Structures Regulates Nuclear Receptor Activities.
    Fuentes-Prior P; Rojas A; Hagler AT; Estébanez-Perpiñá E
    Trends Biochem Sci; 2019 Jan; 44(1):2-6. PubMed ID: 30293659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conformational adaptation of nuclear receptor ligand binding domains to agonists: potential for novel approaches to ligand design.
    Togashi M; Borngraeber S; Sandler B; Fletterick RJ; Webb P; Baxter JD
    J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):127-37. PubMed ID: 15860255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allosteric small molecule modulators of nuclear receptors.
    Meijer FA; Leijten-van de Gevel IA; de Vries RMJM; Brunsveld L
    Mol Cell Endocrinol; 2019 Apr; 485():20-34. PubMed ID: 30703487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Local motifs involved in the canonical structure of the ligand-binding domain in the nuclear receptor superfamily.
    Tsuji M
    J Struct Biol; 2014 Mar; 185(3):355-65. PubMed ID: 24361687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding of ligands and activation of transcription by nuclear receptors.
    Steinmetz AC; Renaud JP; Moras D
    Annu Rev Biophys Biomol Struct; 2001; 30():329-59. PubMed ID: 11340063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nuclear-receptor interactions on DNA-response elements.
    Khorasanizadeh S; Rastinejad F
    Trends Biochem Sci; 2001 Jun; 26(6):384-90. PubMed ID: 11406412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genome-wide identification of nuclear receptor (NR) superfamily genes in the copepod Tigriopus japonicus.
    Hwang DS; Lee BY; Kim HS; Lee MC; Kyung DH; Om AS; Rhee JS; Lee JS
    BMC Genomics; 2014 Nov; 15(1):993. PubMed ID: 25407996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beyond the ligand-binding pocket: targeting alternate sites in nuclear receptors.
    Caboni L; Lloyd DG
    Med Res Rev; 2013 Sep; 33(5):1081-118. PubMed ID: 23344935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting Nuclear Receptors with PROTAC degraders.
    Flanagan JJ; Neklesa TK
    Mol Cell Endocrinol; 2019 Aug; 493():110452. PubMed ID: 31125586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-activity relationship of nuclear receptor-ligand interactions.
    Greschik H; Moras D
    Curr Top Med Chem; 2003; 3(14):1573-99. PubMed ID: 14683516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In-depth proteomic characterization of endogenous nuclear receptors in mouse liver.
    Liu Q; Ding C; Liu W; Song L; Liu M; Qi L; Fu T; Malovannaya A; Wang Y; Qin J; Zhen B
    Mol Cell Proteomics; 2013 Feb; 12(2):473-84. PubMed ID: 23197792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nuclear receptor engineering based on novel structure activity relationships revealed by farnesyl pyrophosphate.
    Goyanka R; Das S; Samuels HH; Cardozo T
    Protein Eng Des Sel; 2010 Nov; 23(11):809-15. PubMed ID: 20817759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Covalent ligands of nuclear receptors.
    Rajan S; Yoon HS
    Eur J Med Chem; 2023 Dec; 261():115869. PubMed ID: 37857142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural features involved in the formation of a complex between the monomeric or the dimeric form of the rev-erb beta DNA-binding domain and its DNA reactive sites.
    Terenzi H; Alzari PM; Zakin MM
    Biochemistry; 1998 Aug; 37(33):11488-95. PubMed ID: 9708984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.